BRIEF published on 04/09/2025 at 10:05, 1 year 5 months ago Katjes International Surpasses 2024 Earnings Expectations Growth Strategy Joint Venture Katjes International Earnings 2024 Confectionery Market
PRESS RELEASE published on 04/09/2025 at 10:00, 1 year 5 months ago Katjes International Exceeds Earnings Guidance for 2024 Katjes International surpasses 2024 earnings guidance with group revenue up 4% to EUR 392.6 million and EBITDA rising 10% to EUR 44.8 million. Joint venture with Shirin David announced Revenue Increase EBITDA Joint Venture Earnings Guidance Katjes International
BRIEF published on 08/23/2024 at 10:05, 2 years 1 month ago Katjes International with Positive Outlook for 2024 Financial Performance 2024 Outlook Sales Growth Katjes International Brand Acquisition
PRESS RELEASE published on 08/23/2024 at 10:00, 2 years 1 month ago Katjes International with positive outlook for the full year 2024 Katjes International expects EUR 390-420 million in net sales for 2024 with an EBITDA margin around 10%, positive full-year outlook Acquisitions EBITDA Margin Net Sales 2024 Forecast Katjes International
BRIEF published on 03/27/2024 at 12:05, 2 years 6 months ago Katjes International Reports Significant Growth in 2023 EBITDA Margin Financial Growth Bond Refinancing Katjes International 2023 Financial Outlook
PRESS RELEASE published on 03/27/2024 at 12:00, 2 years 6 months ago Katjes International growing by 28.1% Katjes International reports significant growth in 2023 with group sales increasing by 28.1% to EUR 377.4 million and EBITDA reaching EUR 40.8 million, exceeding guidance. Audited financial statements available online EBITDA Sales Growth Financial Year 2023 Audited Financial Statements Katjes International
PRESS RELEASE published on 08/24/2023 at 10:23, 3 years 1 month ago EQS-Adhoc: Katjes International offers new corporate bond with a target volume of 110 million euros for exchange and subscription
Published on 09/29/2026 at 00:00, 1 hour 29 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 2 hours 29 minutes ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/28/2026 at 15:00, 10 hours 29 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 10 hours 44 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 10 hours 59 minutes ago Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 22:14, 3 hours 14 minutes ago EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Published on 09/28/2026 at 19:24, 6 hours 4 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 09/28/2026 at 18:00, 7 hours 28 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 17:53, 7 hours 35 minutes ago EQS-Adhoc: MeVis Medical Solutions AG: Forecast Adjustment for Fiscal Year 2025/2026
Published on 09/28/2026 at 17:49, 7 hours 39 minutes ago XTPL increased its global project pipeline in H1 2026, building more sales opportunities for subsequent periods
Published on 09/28/2026 at 17:54, 7 hours 34 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:35, 7 hours 54 minutes ago Disclosure of transactions in own shares from September 21 to September 25, 2026
Published on 09/28/2026 at 08:02, 17 hours 26 minutes ago Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom
